KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Humana (HUM) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to $32.2 billion.

  • Humana's Operating Expenses rose 1248.74% to $32.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $123.4 billion, marking a year-over-year increase of 992.4%. This contributed to the annual value of $115.2 billion for FY2024, which is 1254.19% up from last year.
  • According to the latest figures from Q3 2025, Humana's Operating Expenses is $32.2 billion, which was up 1248.74% from $31.3 billion recorded in Q2 2025.
  • Humana's 5-year Operating Expenses high stood at $32.2 billion for Q3 2025, and its period low was $19.4 billion during Q2 2021.
  • Its 5-year average for Operating Expenses is $25.3 billion, with a median of $25.2 billion in 2023.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 2014.34% in 2023, then skyrocketed by 607.22% in 2025.
  • Quarter analysis of 5 years shows Humana's Operating Expenses stood at $21.0 billion in 2021, then rose by 6.3% to $22.3 billion in 2022, then rose by 20.14% to $26.8 billion in 2023, then rose by 10.99% to $29.8 billion in 2024, then rose by 8.38% to $32.2 billion in 2025.
  • Its last three reported values are $32.2 billion in Q3 2025, $31.3 billion for Q2 2025, and $30.1 billion during Q1 2025.